MedPath

Inreda Diabetic B.V.

🇳🇱Netherlands
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:0
Completed:4

Trial Phases

2 Phases

Phase 2:1
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (66.7%)
Phase 2
1 (33.3%)

Portable Artificial Pancreas Applied for Youth and Adolescents

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 1
First Posted Date
2022-09-16
Last Posted Date
2023-08-14
Lead Sponsor
Inreda Diabetic B.V.
Target Recruit Count
20
Registration Number
NCT05543850
Locations
🇳🇱

Rijnstate Ziekenhuis, Arnhem, Gelderland, Netherlands

Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes

Not Applicable
Completed
Conditions
Type 1 Diabetes
Interventions
Drug: Insulin Lispro Cartridge [Lyumjev]
Drug: Insulin Lispro Cartridge
First Posted Date
2022-08-19
Last Posted Date
2023-04-18
Lead Sponsor
Inreda Diabetic B.V.
Target Recruit Count
12
Registration Number
NCT05508061
Locations
🇳🇱

Rijnstate Hospital, Arnhem, Gelderland, Netherlands

🇳🇱

Slingeland Hospital, Doetinchem, Gelderland, Netherlands

🇳🇱

Hospital Gelderse Vallei, Ede, Gelderland, Netherlands

A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System

Phase 2
Withdrawn
Conditions
Diabetes Mellitus, Type 1
Interventions
First Posted Date
2022-07-12
Last Posted Date
2024-01-03
Lead Sponsor
Inreda Diabetic B.V.
Registration Number
NCT05454709
Locations
🇳🇱

ZGT hospital, Almelo, Overijssel, Netherlands

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.